Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073084262> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2073084262 endingPage "31" @default.
- W2073084262 startingPage "26" @default.
- W2073084262 abstract "Background: Perifosine, a heterocyclic alkylphosphocholine signal transduction inhibitor, has activity against multiple cell types in vitro. This is a phase II study to determine activity and toxicity of perifosine in pancreatic adenocarcinoma. Patients and Methods: Previously untreated patients with locally advanced, unresectable, or metastatic pancreatic adenocarcinoma, performance status Eastern Cooperative Oncology Group 0 or 1, were enrolled. An oral loading dose of 900 mg was followed by 100 mg per day until progression or unacceptable toxicity. Response criteria in solid tumors (RECIST) methodology and a 2-stage design were used. Suspension could occur for inadequate response in the first cohort or for more than 25% grade 3 or greater toxicity. Results: Ten patients were enrolled. Six received 1 month and 4 received 2 months of treatment. Four discontinued therapy as a result of progression and 2 because of clinical deterioration. Three died during treatment. One patient had stable disease but discontinued therapy as a result of unacceptable adverse events (95% confidence interval: 0.3–45%). There were no objective responses and all patients died of progressive disease. Median overall and progression-free survival was 1.85 months (95% confidence interval: 0.9–2.7) and 1.5 months (95% confidence interval: 0.9–1.9) respectively. Conclusion: The study was suspended and subsequently terminated as a result of unacceptable adverse events during the first stage. Perifosine does not appear to be worthy of further study in this group of patients." @default.
- W2073084262 created "2016-06-24" @default.
- W2073084262 creator A5005756097 @default.
- W2073084262 creator A5013408333 @default.
- W2073084262 creator A5029706633 @default.
- W2073084262 creator A5033039101 @default.
- W2073084262 creator A5039867739 @default.
- W2073084262 creator A5083795244 @default.
- W2073084262 date "2007-02-01" @default.
- W2073084262 modified "2023-09-25" @default.
- W2073084262 title "A Phase II Trial of Perifosine in Locally Advanced, Unresectable, or Metastatic Pancreatic Adenocarcinoma" @default.
- W2073084262 cites W1931508686 @default.
- W2073084262 cites W1964584856 @default.
- W2073084262 cites W1967897168 @default.
- W2073084262 cites W1969875009 @default.
- W2073084262 cites W1980376409 @default.
- W2073084262 cites W2019558984 @default.
- W2073084262 cites W2023823393 @default.
- W2073084262 cites W2025486703 @default.
- W2073084262 cites W2027249154 @default.
- W2073084262 cites W2087650046 @default.
- W2073084262 cites W2105092450 @default.
- W2073084262 cites W2128889451 @default.
- W2073084262 cites W2150881991 @default.
- W2073084262 doi "https://doi.org/10.1097/01.coc.0000251235.46149.43" @default.
- W2073084262 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17278891" @default.
- W2073084262 hasPublicationYear "2007" @default.
- W2073084262 type Work @default.
- W2073084262 sameAs 2073084262 @default.
- W2073084262 citedByCount "53" @default.
- W2073084262 countsByYear W20730842622012 @default.
- W2073084262 countsByYear W20730842622013 @default.
- W2073084262 countsByYear W20730842622014 @default.
- W2073084262 countsByYear W20730842622015 @default.
- W2073084262 countsByYear W20730842622016 @default.
- W2073084262 countsByYear W20730842622017 @default.
- W2073084262 countsByYear W20730842622018 @default.
- W2073084262 countsByYear W20730842622019 @default.
- W2073084262 countsByYear W20730842622022 @default.
- W2073084262 countsByYear W20730842622023 @default.
- W2073084262 crossrefType "journal-article" @default.
- W2073084262 hasAuthorship W2073084262A5005756097 @default.
- W2073084262 hasAuthorship W2073084262A5013408333 @default.
- W2073084262 hasAuthorship W2073084262A5029706633 @default.
- W2073084262 hasAuthorship W2073084262A5033039101 @default.
- W2073084262 hasAuthorship W2073084262A5039867739 @default.
- W2073084262 hasAuthorship W2073084262A5083795244 @default.
- W2073084262 hasConcept C121608353 @default.
- W2073084262 hasConcept C126322002 @default.
- W2073084262 hasConcept C141071460 @default.
- W2073084262 hasConcept C197934379 @default.
- W2073084262 hasConcept C2776694085 @default.
- W2073084262 hasConcept C2778822529 @default.
- W2073084262 hasConcept C2779984678 @default.
- W2073084262 hasConcept C2781182431 @default.
- W2073084262 hasConcept C29730261 @default.
- W2073084262 hasConcept C31760486 @default.
- W2073084262 hasConcept C44249647 @default.
- W2073084262 hasConcept C71924100 @default.
- W2073084262 hasConcept C90924648 @default.
- W2073084262 hasConceptScore W2073084262C121608353 @default.
- W2073084262 hasConceptScore W2073084262C126322002 @default.
- W2073084262 hasConceptScore W2073084262C141071460 @default.
- W2073084262 hasConceptScore W2073084262C197934379 @default.
- W2073084262 hasConceptScore W2073084262C2776694085 @default.
- W2073084262 hasConceptScore W2073084262C2778822529 @default.
- W2073084262 hasConceptScore W2073084262C2779984678 @default.
- W2073084262 hasConceptScore W2073084262C2781182431 @default.
- W2073084262 hasConceptScore W2073084262C29730261 @default.
- W2073084262 hasConceptScore W2073084262C31760486 @default.
- W2073084262 hasConceptScore W2073084262C44249647 @default.
- W2073084262 hasConceptScore W2073084262C71924100 @default.
- W2073084262 hasConceptScore W2073084262C90924648 @default.
- W2073084262 hasIssue "1" @default.
- W2073084262 hasLocation W20730842621 @default.
- W2073084262 hasLocation W20730842622 @default.
- W2073084262 hasOpenAccess W2073084262 @default.
- W2073084262 hasPrimaryLocation W20730842621 @default.
- W2073084262 hasRelatedWork W2090874286 @default.
- W2073084262 hasRelatedWork W2114684119 @default.
- W2073084262 hasRelatedWork W2146569819 @default.
- W2073084262 hasRelatedWork W2356374822 @default.
- W2073084262 hasRelatedWork W2605347262 @default.
- W2073084262 hasRelatedWork W2755349712 @default.
- W2073084262 hasRelatedWork W2889701300 @default.
- W2073084262 hasRelatedWork W2898449356 @default.
- W2073084262 hasRelatedWork W3031735911 @default.
- W2073084262 hasRelatedWork W3135121572 @default.
- W2073084262 hasVolume "30" @default.
- W2073084262 isParatext "false" @default.
- W2073084262 isRetracted "false" @default.
- W2073084262 magId "2073084262" @default.
- W2073084262 workType "article" @default.